Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari
Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari
Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
Torrent Pharma Q1 Review: Citi Hikes Target Price — Here’s Why
Citi Research has increased the price target for Torrent Pharmaceuticals Ltd. to Rs 4,380 from Rs 4,000, citing a healthy and in-line quarter and solid traction across the markets. The brokerage maintains a ‘buy’ rating for the firm.
-
Indian Rupee Weakens to 86.83 Against US Dollar: What’s Behind the Slide?
The Indian rupee has weakened to 86.83 against the US dollar, marking its lowest level since June 19. What’s driving the slide and what does it mean for Indian investors and traders?
-
Top 5 Indian Stocks to Buy: Cartrade Tech, Cipla, Vijay Diagnostic Centre, Fortis Healthcare, Dabur India
Discover the top 5 Indian stocks to buy, as recommended by analysts from IDBI Cap, Kushbohra.com, and JM Financial. Learn about Cartrade Tech, Cipla, Vijay Diagnostic Centre, Fortis Healthcare, and Dabur India.
-
Torrent Pharma Share Price Hits New High After Citi Hikes Price Target Following Q1 Results
Shares of Torrent Pharmaceutical Ltd. surged to a record high after the company reported a 20% jump in its quarterly profit and Citi Research increased its price target.
-
Mazagon Dock Share Price: A Deep Dive into the Q1 Earnings Miss and Market Impact
Mazagon Dock Shipbuilders’ share price slumps to a three-month low as the company misses net profit estimates. Dive into the Q1 earnings report and explore the market implications.
-
NTPC Green Energy Shares Swing After Q1 Profit Surges Almost 60%: A Closer Look at the Earnings
NTPC Green Energy shares experienced a sharp intraday fluctuation after the release of its first-quarter earnings for FY26. The company’s robust set of numbers led to an initial rise of 2.35%, but later pared gains to trade 0.40% lower.